NFKB1 and neoplasm: Inhibition of IKKβ, a major activator of NFκB signaling, in ovarian TAMs prevented tumor cell invasion as well as decreased TAM production of M2 immunosuppressive cytokines and increased production of M1-associated IL-12 and NOS2 (59).